Cited by 95Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function

Manelli, Arlene M., Stine, W. Blaine, Van Eldik, Linda J., LaDu, Mary Jo·2004·Journal of Molecular Neuroscience

Abstract

Abnormalities in the processing of amyloid precursor protein to amyloid-beta (Abeta) are causal factors, and the presence of the epsilon4 allele of apolipoprotein E (apoE) is the primary risk factor for Alzheimer's disease (AD). Based, at least in part, on these genetics, the potential structural and functional interactions between these two proteins are the focus of our research. To understand the nature of the physical interactions between apoE and Abeta, we initially utilized gel-shift assays to demonstrate that native apoE2 and E3 (associated with lipid particles) form an SDS-stable complex with Abeta that is more abundant than the apoE4:Abeta complex. We further demonstrated that exogenous apoE3 but not E4 prevents Abeta-induced neurotoxicity by a process that requires apoE receptors. In addition, both exogenous apoE3 and E4 prevent Abeta-induced, glial-mediated inflammation, also via a process that requires apoE receptors. These functional effects all occur at a molar ratio of apoE to Abeta of 1:30. Because the biological activities for both apoE and Abeta are profoundly influenced by their isoform and conformation, respectively, we further investigated the idea that apoE3 and E4 differentially interact with particular aggregation species of Abeta1-42. Our overall hypothesis is that apoE has two general functions in relation to Abeta. First, apoE interacts with oligomeric Abeta via an apoE receptor-mediated process to inhibit neurotoxicity and neuroinflammation (apoE3 >…

Integrity signals

Registry

Crossref · 10.1385/jmn:23:3:235

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Endogenous CNS-derived apoE-containing lipoprotein particles bind to Aβ and promote its clearance and degradation.

    “endogenous CNS-derived apoE-containing lipoprotein particles bind to A␤ and promote its clearance and degradation (DeMattos et al., 2004;Koistinaho et al., 2004;Manelli et al., 2004;Stratman et al., 2005;Trommer et al., 2005)”

    From Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels (2008) · cites this paper as Manelli et al., 2004

The citation lists haven’t been fetched yet

References 82 · Cited by 95

Authors
Manelli, A. M., Stine, W. B., Van Eldik, L. J., & LaDu, M. J.
Affiliations
Northwestern University (US)
Corresponding author
LaDu, Mary Jo
Venue
Journal of Molecular Neuroscience
Published
2004
Volume
23
Issue
3
Pages
235-246
ISSN
0895-8696 (ISSN-L)
OpenAlex
W2331038954
Cited by
95
References
82
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 5 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 5
FWCI
5.34
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Molecular Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Aging (R01AG019121, AG 19121, AG13939, AG 21184, P01AG021184)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
apolipoprotein E, amyloid-beta 42, APOE isoforms, APOE ε4, APOE3, APOE2, Alzheimer's disease, protein-protein interaction, apoE receptors, amyloid-beta oligomers, amyloid-beta aggregation, neurotoxicity, neuroinflammation, glial inflammation, amyloid deposition, protein conformation
MeSH terms
Alzheimer Disease, Animals, Apolipoproteins E, Humans, Neurofibrils, Neurons, Peptide Fragments, Protein Conformation, Risk Factors, Amyloid beta-Peptides, Models, Animal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review